This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_CLL_EXALLC for full statistics.
Chronic lymphocytic leukaemia
C3_CLL
chronic lymphocytic leukemia: B-cell chronic lymphocytic leukemia (B-CLL) is a type of B-cell non-Hodgkin lymphoma (see this term), and the most common form of leukemia in Western countries, affecting elderly adults (mean age of 67 and 72 years) with a slight male predominance (1.7:1), and characterized by a highly variable clinical presentation that can include asymptomatic disease or non-specific B-symptoms such as unintentional weight loss, severe fatigue, fever (without evidence of infection), and night sweats as well as cervical lymphadenopathy, splenomegaly and frequent infections. Some patients can also develop autoimmune complications such as autoimmune hemolytic anemia or immune thrombocytopenia (see these terms). The clinical course is extremely heterogeneous with survival ranging from a few months to several decades.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
969 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
969 |
4. Check minimum number of eventsNone |
969 |
5. Include endpoints |
969 |
6. Filter based on genotype QC (FinnGen only) |
969 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Chronic lymphocytic leukaemia
based on the number of shared cases.
Similar with more cases:
- Chronic lymphocytic leukaemia, helper endpoint
- Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)
- Any event in cancer register
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 969 | 340 | 629 |
| Unadjusted period prevalence (%) | 0.22 | 0.12 | 0.28 |
| Median age at first event (years) | 68.70 | 67.83 | 69.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 878
- Matched controls
- 8779
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
323.0
748
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
52.4
323.0
453
175
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
3601.6
323.0
776
17
XW000
NOMESCO Finland
Bone marrow biopsy
31.5
233.7
319
156
L01BB05
ATC
fludarabine; systemic
1493.8
135.1
128
*
M04AA01
ATC
allopurinol; systemic
6.8
125.5
390
918
L01AA02
ATC
chlorambucil; oral
359.3
124.7
123
*
L03AA02
ATC
filgrastim; parenteral
24.5
123.0
178
90
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
70.3
120.3
137
23
C83.00
ICD-10 Finland
Lymphocytic lymphoma
224.4
115.6
117
6
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
41.4
104.4
131
37
A04AA01
ATC
ondansetron; systemic, rectal
10.2
102.8
220
278
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
287.8
102.1
102
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.0
101.2
219
282
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
47.4
100.9
123
30
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
+∞
86.9
82
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
21.5
85.4
128
69
390
Kela drug reimbursment
Ibrutinib
441.9
82.4
81
*
1512
Kela drug reimbursment
Ibrutinib
828.5
78.6
76
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.3
76.0
274
696
B73
ICPC
Leukaemia
354.0
65.4
65
*
399
Kela drug reimbursment
Venetoclax
652.2
62.6
61
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
172.2
61.8
64
*
L01XE27
ATC
[U] ibrutinib; oral
329.7
61.1
61
*
JN4BD
NOMESCO Finland
Extensive body CT
4.7
60.7
242
663
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
16.0
60.2
100
70
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
37.7
59.6
76
22
L01AA01
ATC
cyclophosphamide; systemic
60.2
57.5
67
12
L03AA13
ATC
pegfilgrastim; parenteral
10.6
57.0
115
123
L01XX52
ATC
venetoclax; oral
538.1
52.0
51
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
21.5
50.6
75
38
WW500
NOMESCO Finland
Blood transfusion
8.3
50.5
118
162
R50.9
ICD-10 Finland
Fever, unspecified
4.0
50.3
232
715
J05AB11
ATC
valaciclovir; oral
4.3
47.9
201
565
1XC02
NOMESCO Finland
NA
29.7
45.3
61
22
L01EL01
ATC
ibrutinib; oral
448.6
43.6
43
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
17.4
42.8
68
42
1518
Kela drug reimbursment
NA
415.5
40.4
40
*
ZX120
NOMESCO Finland
Intravenous
4.2
39.8
170
479
PJA10
NOMESCO Finland
Exploration of lymph nodes
17.3
35.9
57
35
JN6AD
NOMESCO Finland
CT of torso and neck
18.0
35.8
56
33
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
34.6
201
721
ZX108
NOMESCO Finland
Inhalation
25.3
34.3
48
20
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
52.2
33.7
40
8
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.9
33.2
97
180
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
32.5
504
3192
372
Kela drug reimbursment
Idelalisib
+∞
31.4
30
*
212
Kela drug reimbursment
Gout
7.2
29.8
74
110
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.5
29.6
155
510
L01XX47
ATC
[U] idelalisib; oral
+∞
29.3
28
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
29.3
339
1823
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.5
28.7
88
173
2041A
ICD-9 Finland
Lymphoid leukaemia, Chronic
+∞
28.3
27
*
JN4AD
NOMESCO Finland
Body CT examination
3.6
26.4
129
400
J01MA14
ATC
moxifloxacin; systemic
3.4
25.6
136
450
J05AB01
ATC
aciclovir; systemic
2.6
25.2
212
946
9823/3-C77.8
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions
+∞
24.1
23
*
1AA09
NOMESCO Finland
NA
89.2
23.8
26
*
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
34.4
23.5
30
9
C91
ICD-10 Finland
Lymphoid leukaemia
+∞
23.0
22
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
10.5
22.0
43
43
J01MA12
ATC
levofloxacin; systemic
2.3
21.6
235
1193
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
8.5
21.4
47
58
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.1
21.0
68
142
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
112.6
20.6
22
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.6
20.2
60
114
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
13.5
19.8
34
26
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
18.2
19.7
30
17
B02.9
ICD-10 Finland
Zoster without complication
3.8
18.7
82
231
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
18.7
419
2829
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
12.6
18.7
33
27
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.7
18.1
29
19
D70.82
ICD-10 Finland
Drug-induced neutropenia
8.6
17.6
38
46
D70.89
ICD-10 Finland
Neutropenic splenomegaly
10.1
17.3
34
35
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
9.1
16.8
35
40
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
64.6
16.8
19
*
6BA02
NOMESCO Finland
NA
64.6
16.8
19
*
H02AB06
ATC
prednisolone; systemic
1.8
16.7
439
3089
WW200
NOMESCO Finland
Immunization
5.7
16.7
48
88
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.5
16.7
79
238
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
12.5
15.9
28
23
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.6
15.5
124
529
C91.7
ICD-10 Finland
Other lymphoid leukaemia
57.7
14.8
17
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
9.6
14.5
29
31
TGC00
NOMESCO Finland
Bronchial lavation
4.4
14.2
51
120
C90.0
ICD-10 Finland
Multiple myeloma
7.9
14.2
32
42
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
4.8
14.1
47
103
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.7
13.8
47
105
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
13.8
196
1092
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
13.6
220
1285
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
76.3
13.6
15
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
34.6
13.5
17
5
L03AA14
ATC
lipegfilgrastim; parenteral
6.8
13.4
33
50
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
28.8
13.0
17
6
A41.9
ICD-10 Finland
Sepsis, unspecified
3.5
13.0
60
178
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.1
12.9
72
244
L57.0
ICD-10 Finland
Actinic keratosis
2.2
12.8
135
660
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.6
12.5
94
385
ZX112
NOMESCO Finland
Subcutaneous
4.3
12.1
44
106
TQW99
NOMESCO Finland
Other minor procedure on skin
3.0
12.0
70
246
C90.1
ICD-10 Finland
Plasma cell leukaemia
65.8
11.6
13
*
A02BC02
ATC
pantoprazole; systemic
1.7
11.6
556
4474
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
8.5
11.3
24
29
H02AB07
ATC
prednisone; oral
2.0
11.3
153
831
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.2
11.1
117
570
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
6.1
11.0
29
49
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
10.5
254
1679
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
19.0
10.3
15
8
J02AC03
ATC
voriconazole; systemic
23.7
10.3
14
6
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.4
10.2
89
395
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.8
10.2
33
71
J01CA04
ATC
amoxicillin; systemic
1.6
10.1
624
5263
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
6.8
9.9
24
36
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
20.3
9.8
14
7
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.4
9.8
47
145
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
4.7
9.8
32
70
ZZR00
NOMESCO Finland
Flap of skin
4.2
9.7
36
89
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
55.6
9.7
11
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
9.6
68
272
B74
ICPC
Malignant neoplasm blood other
17.7
9.4
14
8
B99
ICPC
Blood/lymph/spleen disease other
15.8
9.0
14
9
A04AA02
ATC
granisetron; systemic, transdermal
2.6
9.0
64
255
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
18.8
8.9
13
7
1CX01
NOMESCO Finland
NA
18.8
8.9
13
7
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
8.1
8.9
19
24
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.5
8.8
70
298
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
5.3
8.7
25
48
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
5.6
8.6
24
44
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
16.5
8.6
13
8
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
90.8
8.4
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
8.3
259
1818
J01DB01
ATC
cefalexin; oral
1.6
8.1
656
5722
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.3
8.1
28
66
B03XA01
ATC
erythropoietin; parenteral
6.4
8.0
20
32
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.5
7.8
60
250
A03
ICPC
Fever
2.0
7.8
98
517
B72
ICPC
Hodgkin Lymphoma
45.4
7.7
9
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
18.5
7.6
11
6
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.9
7.6
117
662
B02
ICPC
Lymph gland(s) enlarged/painful
10.1
7.5
14
14
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.2
7.5
72
339
3AA02
NOMESCO Finland
NA
80.7
7.4
8
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
7.3
129
765
J12.8
ICD-10 Finland
Other viral pneumonia
8.5
7.3
15
18
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
7.3
7
*
9823/3-C77.0
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of head, face and neck
+∞
7.3
7
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
20.2
7.1
10
5
WX892
NOMESCO Finland
Monitored bed care
2.1
7.0
80
405
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
3.0
7.0
38
131
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.3
6.8
32
99
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.7
6.8
140
869
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
5.7
6.8
18
32
B01.9
ICD-10 Finland
Varicella without complication
40.3
6.8
8
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.3
6.7
31
95
122
Kela drug reimbursment
Aplastic anaemia
22.7
6.7
9
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
6.7
276
2049
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
6.6
89
481
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
12.3
6.6
11
9
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
70.3
6.4
7
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
14.4
6.4
10
7
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
11.1
6.3
11
10
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
6.3
46
190
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
18.2
6.3
9
5
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
6.2
124
761
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
6.2
146
944
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
7.7
6.1
13
17
S18
ICPC
Laceration/cut
1.4
6.1
349
2756
B01AB10
ATC
tinzaparin; parenteral
2.1
6.1
64
312
J35.1
ICD-10 Finland
Hypertrophy of tonsils
6.8
6.0
14
21
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
6.8
6.0
14
21
D06BB10
ATC
imiquimod; topical
2.4
6.0
46
194
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
699
1064
20.99
307.65
16.1
3.9
230.12
253.13
u/l
1.93
679
999
504
559
17.70
307.65
4.4
2.7
7.81
11.00
g/l
20.00
481
504
383
251
24.58
307.65
2.8
1.6
—
—
—
0
0
510
841
11.69
307.65
9.2
2.6
71.08
69.02
e9/l
0.51
398
663
601
1120
12.50
307.65
8.2
2.4
1.75
1.81
%
0.66
567
995
253
163
20.65
304.59
1.5
1.6
—
—
—
0
0
230
138
21.54
285.88
8.1
3.5
0.23
1.36
%
2.32
184
112
219
157
17.73
247.71
4.4
6.2
601.18
1185.67
iu/ml
0.30
34
24
152
47
38.17
241.08
2.5
1.3
—
—
—
0
0
152
47
38.17
241.08
2.5
1.3
—
—
—
0
0
320
461
9.87
225.78
3.4
1.9
1.23
1.57
g/l
6.77
282
406
178
122
17.65
204.97
2.2
2.8
3062.61
477.36
u/ml
0.45
18
14
289
437
9.00
193.84
2.0
1.8
1.15
1.51
g/l
0.69
249
397
319
588
7.60
177.97
11.1
3.9
0.13
0.61
%
4.43
210
147
322
620
7.28
171.76
11.6
4.0
0.06
0.13
%
0.96
266
185
785
3555
7.36
156.82
18.9
5.7
1.58
2.89
%
63.84
759
3297
786
3568
7.37
156.44
20.7
6.0
6.06
8.99
%
64.52
759
3319
599
2203
5.50
151.86
9.6
2.9
765.83
8663.78
umol/l
8.03
571
1849
786
3630
7.17
151.35
19.7
5.9
54.99
25.66
%
146.98
758
3350
131
88
17.06
151.33
8.1
3.6
28.95
57.06
%
11.13
76
65
764
3461
6.71
149.82
17.9
5.6
0.41
0.64
%
26.92
738
3218
759
3565
6.21
138.01
16.7
5.7
35.40
58.72
%
135.41
729
3319
102
54
20.99
131.81
2.7
3.1
23.92
38.15
%
2.13
24
20
96
48
22.09
127.09
2.6
2.0
542.31
844.45
e6/l
1.00
36
20
124
103
13.66
126.62
12.2
3.9
—
—
—
0
0
122
108
12.78
119.61
1.1
1.4
106.16
104.80
u/ml
0.04
19
15
751
3897
5.12
109.26
19.1
5.6
0.17
0.20
e9/l
5.83
692
3401
301
802
4.99
107.97
2.3
2.9
63.94
65.92
g/l
3.06
286
722
740
3840
4.92
106.48
15.5
5.6
12.56
1.80
e9/l
31.09
686
3350
172
286
7.10
102.53
2.1
2.5
0.05
0.03
g/l
0.36
163
261
180
329
6.49
97.64
2.2
2.7
0.77
1.57
g/l
1.48
165
284
161
269
6.98
95.27
2.2
2.5
0.00
0.00
g/l
0.50
153
245
185
356
6.19
95.10
2.1
2.5
2.98
3.18
g/l
1.78
158
275
776
4390
4.85
93.74
29.9
8.8
3.40
4.33
e9/l
31.60
733
3819
191
385
5.93
93.43
2.1
2.5
3.09
3.75
g/l
4.32
158
272
191
386
5.92
93.16
2.1
2.5
6.68
7.49
g/l
6.85
158
281
191
386
5.92
93.16
2.1
2.5
—
—
—
0
0
158
266
6.90
92.73
2.2
2.5
0.00
0.00
g/l
0.00
153
244
74
42
18.99
92.17
1.8
1.9
10.19
18.05
%
1.85
21
19
112
127
9.84
92.04
1.2
1.1
—
—
—
0
0
73
42
18.72
90.32
2.0
2.1
—
—
—
0
0
181
360
5.95
89.63
2.1
2.5
8.28
10.71
g/l
7.56
163
303
166
304
6.38
89.56
2.1
2.4
39.24
36.74
g/l
4.71
156
257
106
121
9.71
86.57
1.2
1.1
360.56
333.57
u/ml
0.21
52
61
346
1193
3.96
85.73
8.6
5.8
1.08
1.02
mmol/l
4.42
332
1099
746
4282
4.22
83.67
15.2
6.4
12.32
12.31
umol/l
0.01
729
4055
136
221
7.00
82.24
2.7
1.5
—
—
—
0
0
132
208
7.19
82.16
2.8
1.6
—
—
—
0
0
79
65
13.14
80.51
1.3
1.2
—
—
—
0
0
337
1211
3.73
77.48
1.8
1.5
1.69
2.80
g/l
6.97
282
690
82
76
11.69
77.45
1.5
1.7
—
—
—
0
0
111
161
7.66
74.29
1.2
1.3
—
—
—
0
0
107
154
7.69
72.06
2.9
1.6
—
—
—
0
0
338
1401
3.17
59.43
3.5
3.2
0.82
0.81
mmol/l
0.72
321
1295
96
156
6.72
57.58
1.7
1.4
—
—
—
0
0
684
4282
3.03
54.64
13.3
7.1
1.21
1.21
mmol/l
0.17
598
3602
349
1552
2.95
53.21
3.2
1.9
—
—
—
0
0
145
370
4.43
52.44
3.3
2.8
—
—
—
0
0
40
20
20.82
52.33
3.4
1.5
—
—
—
0
0
39
19
21.35
51.57
1.9
1.4
—
—
—
0
0
66
80
8.78
51.05
3.5
1.6
—
—
—
0
0
67
84
8.49
50.43
3.5
1.6
—
—
—
0
0
81
128
6.81
49.77
1.7
1.5
—
—
—
0
0
242
907
3.22
49.41
4.5
2.8
8.81
9.99
umol/l
0.26
229
802
634
3930
2.77
49.38
11.8
6.2
1.21
1.21
mmol/l
0.08
604
3533
44
31
14.82
48.74
1.4
1.3
—
—
—
0
0
566
3336
2.68
48.46
25.9
10.3
0.00
0.00
e9/l
0.01
485
2726
80
130
6.62
47.84
2.0
1.5
—
—
—
0
0
51
48
11.16
47.40
7.4
2.5
—
—
—
0
0
84
151
6.00
45.40
1.4
1.2
120.39
53.21
u/l
0.74
76
127
286
1234
2.87
45.01
2.8
2.6
23.24
22.11
%
0.61
251
1046
35
19
19.07
44.07
1.1
1.5
—
—
—
0
0
597
3720
2.58
43.84
7.0
5.0
34.74
34.51
g/l
0.37
568
3438
292
1293
2.80
43.56
2.7
2.6
2.23
2.25
g/l
0.22
278
1198
261
1103
2.87
42.40
2.6
1.9
—
—
—
0
0
261
1103
2.87
42.40
2.5
1.8
—
—
—
0
0
77
136
6.06
42.33
1.9
1.4
—
—
—
0
0
58
78
7.85
41.10
3.7
1.5
—
—
—
0
0
58
78
7.85
41.10
3.7
1.5
—
—
—
0
0
58
78
7.85
41.10
3.7
1.5
—
—
—
0
0
298
1397
2.64
39.13
2.8
2.6
13.27
12.23
umol/l
1.37
285
1297
68
119
6.07
37.69
1.9
1.5
—
—
—
0
0
117
329
3.91
36.68
2.2
3.7
62.56
77.11
mg/l
0.30
108
270
63
105
6.35
36.65
1.8
1.7
—
—
—
0
0
117
330
3.90
36.52
2.1
3.7
31.47
86.28
mg/l
0.84
107
274
801
6107
2.80
33.35
21.3
7.8
83.22
80.59
u/l
0.96
778
5691
70
146
5.09
32.05
8.3
3.3
30.13
59.57
%
19.11
70
146
129
424
3.36
31.84
2.3
1.8
1.02
1.95
ug/l
0.60
113
370
38
45
8.75
29.79
4.7
1.5
—
—
—
0
0
38
45
8.75
29.79
4.7
1.5
—
—
—
0
0
38
45
8.75
29.79
4.6
1.5
—
—
—
0
0
38
45
8.75
29.79
4.7
1.5
—
—
—
0
0
86
228
4.04
29.12
1.4
1.4
—
—
—
0
0
479
3060
2.12
28.47
3.9
2.8
451.61
157.99
ug/l
1.51
440
2740
32
32
10.31
28.39
5.3
1.6
—
—
—
0
0
32
32
10.31
28.39
5.3
1.6
—
—
—
0
0
359
2068
2.17
27.79
6.2
4.2
83.15
84.03
%
0.27
351
2024
32
33
9.99
27.78
5.3
1.6
—
—
—
0
0
32
33
9.99
27.78
2.0
1.8
5707.31
1571.48
u/ml
1.53
32
33
378
2258
2.11
26.30
2.7
2.2
4.06
3.14
mg/l
4.51
332
1901
24
18
13.65
25.46
1.3
1.2
—
—
—
0
0
267
1411
2.23
25.26
2.3
1.9
29.40
29.97
s
0.81
257
1363
26
23
11.59
24.98
1.5
1.2
—
—
—
0
0
536
3704
2.00
24.28
7.9
4.3
—
—
—
0
0
25
22
11.64
24.09
1.0
1.3
—
—
—
0
0
157
669
2.61
23.97
1.9
1.7
—
—
—
0
0
75
208
3.82
23.80
1.7
1.3
—
—
—
0
0
75
208
3.82
23.80
1.7
1.3
—
—
—
0
0
339
2013
2.05
23.39
4.8
2.5
—
—
—
0
0
24
21
11.69
23.19
1.8
1.3
—
—
—
0
0
36
57
6.52
21.94
1.3
1.4
—
—
—
0
0
653
4954
1.98
21.24
7.1
5.1
6.83
6.87
mmol/l
0.20
639
4678
46
98
4.88
20.51
2.5
3.0
—
—
—
0
0
717
5661
2.02
20.24
6.4
4.1
13.96
14.35
mm/h
0.20
675
5143
86
290
3.16
20.15
1.6
1.3
—
—
—
0
0
54
135
4.18
19.74
1.3
1.3
—
—
—
0
0
32
51
6.45
19.37
2.8
1.7
—
—
—
0
0
59
160
3.86
19.31
1.6
1.5
30.53
30.86
g/l
0.06
53
142
137
609
2.46
18.93
2.0
1.7
—
—
—
0
0
16
10
16.25
18.54
1.4
2.2
—
—
—
0
0
398
2667
1.84
18.05
3.8
3.5
43.08
107.90
e6/l
1.69
325
2113
450
3165
1.79
17.10
3.8
3.5
—
—
—
0
0
414
2843
1.80
17.05
4.8
3.5
2.34
2.34
mmol/l
0.31
365
2428
36
73
5.08
16.99
1.2
1.1
171.17
162.31
miu/ml
—
6
17
26
39
6.82
16.64
1.4
1.2
—
—
—
0
0
340
2228
1.81
16.18
1.9
1.6
20.83
20.08
nmol/l
0.39
310
1876
164
840
2.15
16.10
5.9
7.3
10.73
11.06
mmol/l
0.24
156
801
16
13
12.50
16.06
1.0
1.5
—
—
—
0
0
16
13
12.50
16.06
1.4
1.1
—
—
—
0
0
27
44
6.28
15.99
1.0
1.2
—
—
—
0
0
51
143
3.71
15.92
1.2
1.1
—
—
—
0
0
24
35
7.01
15.75
11.0
2.3
202.00
201.31
u/l
0.02
24
35
17
16
10.80
15.57
1.1
1.0
—
—
—
0
0
50
145
3.58
14.86
1.7
1.4
1952.61
1566.67
e6/l
0.29
41
104
47
131
3.72
14.80
1.7
1.4
91998.03
102692.29
e6/l
0.05
31
79
27
48
5.76
14.67
1.9
1.6
—
—
—
0
0
358
2445
1.74
14.41
3.7
3.4
0.38
0.53
e6/l
0.94
289
1896
41
107
3.96
14.16
3.0
3.7
—
—
—
0
0
419
3005
1.69
13.99
4.5
4.0
77.92
115.80
e6/l
0.63
335
2239
270
1722
1.79
13.67
3.8
4.1
338.72
319.17
ng/l
0.04
235
1498
29
60
4.95
13.38
1.8
1.5
—
—
—
0
0
486
3665
1.65
13.10
2.6
2.1
93.83
93.08
pmol/l
0.13
303
1891
287
1884
1.74
13.05
3.2
2.7
3.94
4.25
e6/l
0.27
254
1656
63
230
2.86
12.83
1.4
1.5
0.03
0.14
iu/ml
1.06
19
49
25
48
5.32
12.53
1.9
1.6
—
—
—
0
0
22
39
5.75
11.99
2.1
5.7
—
36.00
—
0
8
13
12
10.97
11.98
1.2
1.1
—
—
—
0
0
84
369
2.40
11.80
4.7
1.9
—
—
—
0
0
28
63
4.55
11.72
1.1
1.0
—
—
—
0
0
79
340
2.44
11.61
2.9
1.7
—
—
—
0
0
644
5302
1.64
11.54
5.5
4.9
880.33
2355.28
e6/l
0.62
12
99
336
2363
1.65
11.54
5.8
3.3
37.47
35.31
u/l
0.30
325
2248
54
193
2.90
11.44
1.3
1.3
—
—
—
0
0
19
31
6.23
11.23
1.1
1.1
—
—
—
0
0
30
74
4.15
11.20
1.1
1.1
—
—
—
0
0
23
46
5.10
11.03
3.1
3.8
—
—
—
0
0
248
1633
1.70
10.86
1.8
1.6
1.90
1.42
mg/l
0.69
206
1283
26
59
4.50
10.78
2.0
1.5
—
—
—
0
0
16
9
18.05
10.74
3.6
2.3
—
—
—
0
0
30
77
3.99
10.63
2.1
1.6
—
—
—
0
0
26
60
4.43
10.56
2.0
1.5
—
—
—
0
0
107
548
2.07
10.35
1.6
1.5
—
—
—
0
0
113
606
1.98
9.62
4.3
4.1
4.99
5.16
kpa
1.34
99
562
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
37
5.22
9.39
1.2
1.1
—
—
—
0
0
438
3404
1.52
9.22
2.9
2.3
—
—
—
0
0
63
275
2.38
9.00
1.8
1.6
—
—
—
0
0
141
834
1.81
8.87
8.0
7.3
1.11
1.41
mmol/l
4.66
136
796
389
2967
1.52
8.84
3.0
3.1
1902.06
1766.93
ng/l
0.24
355
2595
217
1448
1.64
8.83
3.1
3.2
1.71
1.73
e6/l
0.02
126
855
47
181
2.68
8.71
1.7
1.4
—
—
—
0
0
20
44
4.62
8.62
2.3
1.5
—
—
—
0
0
20
44
4.62
8.62
2.3
1.5
—
—
—
0
0
68
313
2.26
8.61
1.8
2.0
42.23
38.35
u/l
0.64
62
271
105
572
1.94
8.53
4.4
4.1
1.98
1.99
mmol/l
0.01
77
436
16
29
5.59
8.52
1.1
1.0
—
—
—
0
0
8
0
+∞
8.34
1.0
0.0
—
—
—
0
0
57
247
2.39
8.29
2.6
3.4
24.63
25.01
mmol/l
0.25
45
210
13
20
6.57
8.08
1.2
1.1
—
—
—
0
0
13
20
6.57
8.08
1.2
1.1
—
—
—
0
0
11
14
7.94
8.00
1.3
1.2
—
—
—
0
0
125
738
1.80
7.89
2.1
2.4
34.19
32.80
u/l
0.23
115
617
471
3799
1.47
7.82
11.4
11.4
1.30
1.34
inr
0.42
127
1029
27
82
3.36
7.56
1.1
1.2
65.28
52.38
u/l
0.52
18
61
261
1881
1.53
7.50
2.0
1.8
1161.12
1184.46
nmol/l
0.15
201
1392
812
7369
1.63
7.19
41.8
17.7
26.35
27.96
mg/l
0.70
751
6042
140
888
1.67
6.83
2.6
3.1
234.19
235.24
ng/l
0.01
124
820
28
93
3.07
6.81
2.2
2.4
—
—
—
0
0
237
1704
1.52
6.80
4.3
3.2
2.45
2.46
mmol/l
0.87
215
1483
216
1523
1.54
6.78
3.1
3.0
0.92
1.01
e6/l
0.22
125
922
10
6
16.82
6.75
1.2
1.0
—
—
—
0
0
10
6
16.82
6.75
1.0
1.3
—
—
—
0
0
47
207
2.34
6.63
2.7
3.3
7.62
7.57
kpa
0.09
38
186
115
698
1.73
6.59
1.5
1.3
—
—
—
0
0
140
899
1.65
6.51
3.7
3.7
2.06
2.09
mmol/l
0.03
110
720
20
56
3.63
6.34
1.1
1.2
—
—
—
0
0
111
676
1.73
6.28
1.9
2.2
421.66
376.87
nmol/l
1.58
104
611
178
1224
1.56
6.22
9.1
6.9
104.25
104.22
mmol/l
0.03
171
1194
131
839
1.65
6.15
1.8
2.3
0.19
0.20
g/l
1.18
118
780
12
23
5.27
6.02
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
67
355
1.95
5.93
3.4
2.4
0.36
0.33
u/ml
0.29
43
200
27
96
2.86
5.87
2.2
1.6
—
—
—
0
0
167
1147
1.55
5.85
8.0
7.3
1.15
1.31
mmol/l
0.25
133
888
10
9
11.21
5.80
1.2
1.2
—
—
—
0
0
27
98
2.81
5.66
2.1
1.5
—
—
—
0
0
27
98
2.81
5.66
2.2
1.5
—
—
—
0
0
27
98
2.81
5.66
2.2
1.5
—
—
—
0
0
42
190
2.27
5.61
2.9
2.5
13.36
15.70
%
1.80
19
90
27
99
2.78
5.56
2.1
1.5
—
—
—
0
0
164
1145
1.52
5.31
8.5
7.3
4.91
5.11
kpa
1.85
158
1093
11
22
5.05
5.27
1.2
1.1
—
—
—
0
0
14
35
4.04
5.18
1.3
1.2
—
—
—
0
0
26
98
2.70
5.11
2.2
1.5
—
—
—
0
0
163
1146
1.51
5.10
8.5
7.3
11.32
11.75
kpa
0.46
157
1094
8
6
13.43
5.08
2.3
2.7
—
—
—
0
0
8
6
13.43
5.08
2.0
2.0
1.63
1.75
%
—
8
6
661
5899
1.38
5.05
50.4
21.4
14.67
13.94
%
23.88
653
5761
11
23
4.83
5.02
1.2
1.1
—
—
—
0
0
43
208
2.12
4.91
2.9
1.3
1.10
1.14
g/l
0.32
43
198
30
126
2.43
4.76
1.4
1.1
—
—
—
0
0
41
199
2.11
4.66
1.3
1.6
—
—
—
0
0
12
29
4.18
4.63
1.0
1.2
—
—
—
0
0
513
4437
1.33
4.62
3.1
3.3
52.82
57.07
u/l
0.43
466
4040
7
5
14.09
4.58
2.6
1.0
—
—
—
0
0
370
3055
1.34
4.56
2.1
2.2
83.88
79.09
nmol/l
2.47
327
2636
21
76
2.80
4.47
1.1
1.2
1.67
5.65
u/ml
—
6
20
30
131
2.33
4.39
1.3
1.3
—
—
—
0
0
9
12
7.56
4.36
1.0
1.1
—
—
—
0
0
59
336
1.80
4.25
1.4
1.2
24.45
244.70
u/ml
8.11
39
301
64
376
1.75
4.16
5.4
4.5
25.30
25.06
mmol/l
0.25
57
350
693
6316
1.34
4.07
42.5
19.3
37.42
38.68
%
2.58
451
3879
28
123
2.31
4.06
2.4
1.8
89.26
88.97
%
0.12
28
123
8
10
8.06
4.06
1.1
1.3
—
—
—
0
0
38
190
2.04
4.03
2.5
2.4
107.69
128.21
g/l
3.28
26
139
7
7
10.06
4.01
1.3
1.0
—
—
—
0
0
8
11
7.32
3.86
1.3
1.3
—
—
—
0
0
20
77
2.63
3.82
1.1
1.2
—
—
—
0
0
11
29
3.83
3.81
1.2
1.2
176.85
32.71
ug/l
—
6
13
6
5
12.06
3.76
1.3
1.0
—
—
—
0
0
6
5
12.06
3.76
1.3
1.0
106.33
101.40
%
—
6
5
29
134
2.20
3.76
1.2
1.1
—
—
—
0
0
310
2554
1.31
3.73
2.4
2.5
55.66
57.72
u/l
0.43
285
2353
12
35
3.46
3.62
1.1
1.1
—
—
—
0
0
35
179
1.99
3.52
1.4
1.6
—
—
—
0
0
174
1330
1.38
3.43
23.7
30.0
1.51
1.41
inr
0.36
33
167
7
10
7.04
3.36
1.0
1.2
—
—
—
0
0
7
10
7.04
3.36
1.0
1.3
—
—
—
0
0
132
984
1.40
3.02
3.4
4.1
8.55
26.48
ug/l
1.14
100
827
15
57
2.66
2.97
1.5
1.6
1.67
9.61
u/l
—
9
31
6
9
6.70
2.87
1.3
1.2
—
—
—
0
0
16
65
2.49
2.80
1.3
1.1
—
—
—
0
0
10
31
3.25
2.78
1.0
1.1
—
—
—
0
0
14
54
2.62
2.71
1.1
1.0
—
—
—
0
0
6
10
6.03
2.70
1.3
1.0
—
—
—
0
0
25
126
2.01
2.67
4.0
6.6
10.63
12.38
mg/l
1.04
17
118
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
15
4.69
2.60
1.0
2.2
196.47
190.53
%
—
7
15
18
82
2.22
2.48
1.1
1.2
1.83
6.80
u/ml
—
6
41
669
7118
0.81
2.45
4.4
4.8
1.26
1.42
mmol/l
16.39
595
6365
16
71
2.27
2.35
1.3
1.1
—
—
—
0
0
9
28
3.23
2.31
2.1
3.0
—
—
—
0
0
9
29
3.12
2.23
1.1
1.1
—
—
—
0
0
75
537
1.43
2.20
1.4
1.4
—
—
—
0
0
9
30
3.02
2.15
1.2
1.0
—
—
—
0
0
16
75
2.15
2.09
1.0
1.1
—
—
—
0
0
5
10
5.02
2.07
1.2
1.2
—
—
—
0
0
681
7191
0.82
2.05
4.4
4.8
4.27
4.41
mmol/l
2.73
608
6495
6
15
4.02
2.04
1.0
1.1
—
—
—
0
0
40
255
1.59
2.04
3.5
3.4
0.78
0.86
nmol/l
0.36
26
204
732
6935
1.23
2.01
36.1
16.6
72.20
73.08
ml/min/173m2
0.62
664
5773
667
7049
0.83
1.98
6.0
6.7
39.06
41.10
mmol/mol
7.48
591
6411
39
250
1.58
1.95
3.3
3.2
181.87
65.51
u/ml
0.46
39
241
703
7384
0.83
1.90
5.0
5.5
2.56
2.55
mmol/l
0.12
625
6631
9
34
2.66
1.86
1.4
1.2
—
—
—
0
0
16
79
2.04
1.86
1.6
1.2
—
—
—
0
0
810
7780
1.25
1.83
27.7
11.4
24.05
25.42
u/l
2.00
792
7433
814
7832
1.25
1.75
39.8
21.2
139.44
139.60
mmol/l
0.80
798
7612
82
1057
0.76
1.66
12.5
8.6
—
—
—
0
0
30
189
1.61
1.64
2.5
3.5
19.83
1654.29
u/ml
0.68
25
175
411
3743
1.17
1.63
3.9
4.0
0.00
0.00
estimate
0.00
83
716
814
7847
1.23
1.62
43.4
21.3
4.04
4.01
mmol/l
2.77
795
7618
292
2601
1.18
1.51
1.8
2.2
153.28
239.77
u/l
1.40
268
2430
657
6894
0.85
1.50
4.0
4.3
1.31
1.28
mmol/l
0.45
584
6114
20
116
1.74
1.49
1.2
1.2
15.67
7.85
u/l
1.50
14
87
92
729
1.29
1.48
7.2
3.7
1.22
1.22
mmol/l
0.41
87
633
408
3736
1.16
1.48
5.4
5.4
0.00
0.00
estimate
0.00
87
713
381
3471
1.16
1.48
4.2
4.2
172.43
56.03
ng/l
0.40
313
2707
176
2043
0.83
1.44
1.6
1.6
1.42
1.33
mmol/l
0.62
147
1678
116
957
1.24
1.35
4.7
3.6
—
—
—
0
0
84
667
1.28
1.35
3.0
4.0
79.00
98.21
ng/l
1.87
72
579
9
43
2.10
1.30
1.3
1.0
—
—
—
0
0
16
92
1.75
1.25
1.6
1.3
0.69
0.67
nmol/l
0.08
16
84
410
3790
1.14
1.25
3.9
4.1
0.04
0.00
estimate
0.49
85
693
11
56
1.98
1.22
1.2
1.2
—
62.00
—
0
8
17
102
1.68
1.16
1.5
1.5
—
—
—
0
0
0
29
0.00
0.98
0.0
1.1
—
315.83
—
0
18
0
32
0.00
0.95
0.0
1.8
—
48.59
—
0
22
87
1029
0.83
0.90
1.2
1.2
26.94
15.36
u/ml
0.29
19
348
8
43
1.87
0.87
1.6
1.4
1.12
0.96
g/l
—
8
43
6
30
2.01
0.87
1.0
1.2
—
71.20
%
—
0
5
6
32
1.88
0.82
2.5
1.5
36.98
56.57
ug/l
—
6
32
708
7287
0.89
0.81
5.6
5.1
6.05
6.13
mmol/l
1.17
639
6472
93
1081
0.85
0.81
1.3
1.2
43.19
43.47
iu/ml
0.01
29
343
176
1949
0.88
0.80
1.7
1.8
268613578.73
10025971.46
pmol/l
0.68
137
1566
6
33
1.82
0.79
1.2
3.2
—
—
—
0
0
6
33
1.82
0.79
1.2
3.2
—
—
—
0
0
817
7992
1.14
0.79
59.4
26.0
124.12
133.54
g/l
43.45
804
7825
22
158
1.40
0.75
1.2
1.2
6.13
60.39
e6/l
0.85
16
128
816
7989
1.14
0.74
59.2
25.9
190.52
237.59
e9/l
54.57
800
7738
816
7990
1.13
0.74
59.1
25.9
4.13
4.41
e12/l
32.31
798
7706
17
242
0.70
0.73
2.2
2.5
90.42
85.21
ug/min
—
9
141
816
7991
1.13
0.73
59.2
25.9
20.85
6.87
e9/l
42.61
797
7707
42
336
1.26
0.71
2.3
3.2
4.10
4.32
pmol/l
1.01
34
289
263
2828
0.90
0.71
4.0
4.0
16.14
9.43
mg/mmol
0.73
172
1822
38
301
1.27
0.70
4.0
3.8
3.92
3.97
mmol/l
0.25
33
277
52
624
0.82
0.67
1.6
1.7
1.63
1.63
%
0.00
42
506
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
15
104
1.45
0.62
1.0
1.2
—
—
—
0
0
15
211
0.71
0.62
1.3
1.5
—
—
—
0
0
25
321
0.77
0.59
2.0
1.8
—
—
—
0
0
20
149
1.35
0.58
1.5
1.6
—
—
—
0
0
43
363
1.19
0.49
4.0
3.7
1.24
1.42
mmol/l
0.63
43
354
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
14
188
0.74
0.47
1.2
1.4
—
—
—
0
0
557
5415
1.07
0.45
3.6
3.7
15.14
15.09
pmol/l
0.15
494
4766
95
1044
0.90
0.42
4.3
4.9
29.45
32.58
%
1.64
60
671
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
38
323
1.18
0.42
1.0
1.1
158.83
132.18
iu/ml
—
10
111
28
233
1.21
0.39
1.4
1.5
235.57
271.21
ug/g
0.48
19
144
12
89
1.35
0.38
1.1
1.0
—
—
—
0
0
25
209
1.20
0.34
2.8
1.8
—
—
—
0
0
277
2884
0.94
0.33
4.5
4.4
—
—
—
0
0
6
47
1.28
0.32
1.2
2.3
—
—
—
0
0
159
1678
0.94
0.30
4.3
4.6
1.02
1.02
kg/l
0.60
18
253
69
631
1.10
0.29
1.9
2.2
11.04
12.61
nmol/l
0.70
55
548
17
201
0.84
0.24
4.3
3.9
28.08
28.38
mg/l
0.01
11
127
5
39
1.28
0.23
2.4
1.2
—
—
—
0
0
5
39
1.28
0.23
2.4
1.2
—
—
—
0
0
10
79
1.27
0.22
1.1
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
5.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
22
250
0.88
0.20
1.0
1.0
—
—
—
0
0
676
6685
1.04
0.19
4.5
4.6
2.27
2.07
mu/l
1.83
609
5926
24
215
1.12
0.16
1.2
1.2
—
—
—
0
0
67
633
1.06
0.16
3.5
3.1
61.97
58.23
ml/min/173m2
0.49
40
265
308
3144
0.97
0.15
4.3
4.7
21.99
21.42
%
0.25
153
1639
24
216
1.11
0.15
1.2
1.2
—
—
—
0
0
228
2225
1.03
0.14
2.8
3.3
0.79
0.79
ug/l
0.01
170
1574
22
243
0.90
0.14
1.4
1.3
—
—
—
0
0
261
2660
0.97
0.12
3.2
3.3
1219.54
283.09
mg/l
1.17
171
1737
393
3886
1.02
0.09
4.9
5.5
10.39
3.52
ug/l
0.40
352
3429
29
272
1.07
0.09
1.4
1.3
—
—
—
0
0
6
54
1.11
0.09
1.2
1.1
—
—
—
0
0
6
58
1.03
0.08
3.0
2.5
—
—
—
0
0
90
881
1.02
0.05
2.2
2.6
5.32
6.69
ug/l
0.41
72
771
209
2109
0.99
0.04
4.3
4.4
0.00
0.00
estimate
0.50
85
676
10
93
1.08
0.02
1.9
1.5
—
—
—
0
0
14
136
1.03
0.00
1.1
1.6
3.04
5.71
iu/l
—
5
39
269
2685
1.00
0.00
3.2
3.2
7.27
7.41
mmol/l
0.22
225
2203
134
1338
1.00
0.00
1.2
1.2
4.41
1.35
u/ml
0.36
15
336
9
99
0.91
0.00
3.4
4.7
371.11
354.22
umol/l
—
9
88
0
6
0.00
0.00
0.0
1.0
—
25.93
—
0
6
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_CLL – Chronic lymphocytic leukaemia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).